Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $130.96 ($1.2M) on 2016-11-10, disclosed to the SEC on 2016-11-14.
Seasonal sale ($1.2M) by Director — this insider has traded UTHR in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.96 | 2,295 | $301K | 24.1% |
| 2 | $130.96 | 2,295 | $301K | 24.1% |
| 3 | $131.67 | 2,205 | $290K | 23.3% |
| 4 | $131.67 | 2,205 | $290K | 23.3% |
| 5 | $132.51 | 500 | $66K | 5.3% |
| Total | $131.37 avg | 9,500 |
| $1.2M |
| 100% |
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |